Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin.
about
Identification of the Calmodulin-Binding Domains of Fas Death ReceptorPARP-1 regulates resistance of pancreatic cancer to TRAIL therapy.Histamine regulation of hyperplastic and neoplastic cell growth in cholangiocytes.Recent advances in the regulation of cholangiocarcinoma growthCholesterol depletion by methyl-β-cyclodextrin augments tamoxifen induced cell death by enhancing its uptake in melanoma.α-Mangostin from Cratoxylum arborescens demonstrates apoptogenesis in MCF-7 with regulation of NF-κB and Hsp70 protein modulation in vitro, and tumor reduction in vivo.Involvement of NF-κB and HSP70 signaling pathways in the apoptosis of MDA-MB-231 cells induced by a prenylated xanthone compound, α-mangostin, from Cratoxylum arborescensPathogenesis, diagnosis, and management of cholangiocarcinomaCurcumin suppresses proliferation and induces apoptosis in human biliary cancer cells through modulation of multiple cell signaling pathways.Targeting the Anti-Apoptotic Protein c-FLIP for Cancer Therapy.Structural and biophysical characterization of the interactions between the death domain of Fas receptor and calmodulin.Targeting the Fas/FasL signaling pathway in cancer therapy.Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).Calmodulin antagonists promote TRA-8 therapy of resistant pancreatic cancerCalmodulin as a potential target by which berberine induces cell cycle arrest in human hepatoma Bel7402 cells.Reduced CaM/FLIP binding by a single point mutation in c-FLIP(L) modulates Fas-mediated apoptosis and decreases tumorigenesis.Calmodulin mediates Fas-induced FADD-independent survival signaling in pancreatic cancer cells via activation of Src-extracellular signal-regulated kinase (ERK).Tamoxifen enhances therapeutic effects of gemcitabine on cholangiocarcinoma tumorigenesis.Animal models of cholangiocarcinoma.Increased ETV4 expression correlates with estrogen-enhanced proliferation and invasiveness of cholangiocarcinoma cells.
P2860
Q28552166-B40EC5EC-D091-42C9-8EA5-0EF09E66FB77Q33731141-D1A28219-97AE-4763-9434-F6EBE8747E75Q33909909-D0FF74D9-8C2D-43E8-89FC-4B54A570BB76Q33994814-27957CCE-10ED-4B79-B2F7-F2CEE8947904Q34246496-0307E639-6B7F-4DC8-BBA0-3F8D9CE90E4EQ34306509-40C4ED06-426D-4777-8B18-A4560B265AC7Q34489084-5FD971B5-77A6-4798-BD0D-151DA2642866Q34656747-84C4CF99-1A0A-47E0-A98E-C566EA05F51EQ35190775-FF8EFB61-D700-4F45-BEF9-F679B8326EF1Q35762274-8D7C8AB1-D931-45FE-964C-18EF06D274F1Q37048442-C94A78D3-258D-41DC-9F24-512F84E4C565Q37975245-004B7737-6395-4555-ABD6-46B9D7D6F14BQ38812588-8789EB07-63DA-4B3F-A27D-42001663B6E3Q38839654-B907AF31-7BB7-43D9-B51E-D471B6F85196Q39192041-1D02A937-7D38-49FA-BACA-141B17B95238Q39474971-D7D7A6A8-2A22-4B7F-99E1-F4C616C11FE2Q39536531-C3C94FB7-BF00-4A65-A118-544A1447F1A7Q39564543-E5EBC4AC-C8EC-41B4-8EE9-B366D7E852B9Q52720960-A742A759-706E-4507-96F9-791F95D26170Q55387968-B3EBAC31-0C0D-4534-ACC7-C2E3D3CD5911
P2860
Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin.
@ast
Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin.
@en
Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin.
@nl
type
label
Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin.
@ast
Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin.
@en
Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin.
@nl
prefLabel
Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin.
@ast
Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin.
@en
Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin.
@nl
P2093
P2860
P1476
Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin.
@en
P2093
Chang Hyun Byon
Eun-Young Ahn
Jay M McDonald
Juan P Arnoletti
Nirag Jhala
Pritish Pawar
Yabing Chen
P2860
P304
P356
10.1158/1078-0432.CCR-08-1150
P407
P577
2009-02-01T00:00:00Z